251 related articles for article (PubMed ID: 6319678)
1. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
[TBL] [Abstract][Full Text] [Related]
2. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptor regulation of NG108-15 adenylate cyclase: requirement for Na+ and GTP.
Lichtshtein D; Boone G; Blume A
J Cyclic Nucleotide Res; 1979 Oct; 5(5):367-75. PubMed ID: 521545
[TBL] [Abstract][Full Text] [Related]
4. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
Costa T; Klinz FJ; Vachon L; Herz A
Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
[TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated inhibitions of NG108-15 adenylate cyclase: essential role of Na+ and GTP.
Blume AJ; Lichtshtein D; Boone G
Adv Biochem Psychopharmacol; 1980; 21():339-48. PubMed ID: 6246750
[No Abstract] [Full Text] [Related]
6. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
Law PY; Hom DS; Loh HH
Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
[TBL] [Abstract][Full Text] [Related]
7. Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma x glioma (NG108-15) hybrid cells chronically exposed to an opioid.
Ammer H; Schulz R
Mol Pharmacol; 1993 Apr; 43(4):556-63. PubMed ID: 8386308
[TBL] [Abstract][Full Text] [Related]
8. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
Graeser D; Neubig RR
Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced down-regulation of muscarinic cholinergic and alpha 2-adrenergic receptors after inactivation of Ni by pertussis toxin.
Thomas JM; Hoffman BB
Endocrinology; 1986 Sep; 119(3):1305-14. PubMed ID: 2426098
[TBL] [Abstract][Full Text] [Related]
10. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
Selley DE; Breivogel CS; Childers SR
Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling of alpha-adrenoceptor-mediated inhibition of human platelet adenylate cyclase by N-ethylmaleimide.
Jakobs KH; Lasch P; Minuth M; Aktories K; Schultz G
J Biol Chem; 1982 Mar; 257(6):2829-33. PubMed ID: 6277915
[TBL] [Abstract][Full Text] [Related]
12. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
Woodcock EA; Johnston CI
Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
[TBL] [Abstract][Full Text] [Related]
13. Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranes.
Waelbroeck M; Robberecht P; Chatelain P; Christophe J
J Cyclic Nucleotide Res; 1981; 7(3):173-85. PubMed ID: 7287969
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of high and low affinity guanosine 5'-triphosphate binding sites in the regulation of follicle-stimulating hormone binding to receptor and signal transduction in bovine calf testis membranes.
Zhang SB; Dattatreyamurty B; Reichert LE
Endocrinology; 1991 Jan; 128(1):295-302. PubMed ID: 1898882
[TBL] [Abstract][Full Text] [Related]
15. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
16. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
Law PY; Bergsbaken C
J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
[TBL] [Abstract][Full Text] [Related]
17. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
Prather PL; Loh HH; Law PY
Mol Pharmacol; 1994 May; 45(5):997-1003. PubMed ID: 8190115
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase.
Huff RA; Abou-Donia MB
Neurotoxicology; 1995; 16(2):281-90. PubMed ID: 7566687
[TBL] [Abstract][Full Text] [Related]
19. Heterologous up-regulation of Ni-coupled receptors in cultured neural hybrid cells by a transferable factor, whose expression is inhibited in a cyclic AMP-dependent, cell-specific manner.
Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
Mol Pharmacol; 1987 Nov; 32(5):669-77. PubMed ID: 2824982
[TBL] [Abstract][Full Text] [Related]
20. Further evidence that muscarinic cholinergic receptors of 1321N1 astrocytoma cells couple to a guanine nucleotide regulatory protein that is not Ni.
Martin MW; Evans T; Harden TK
Biochem J; 1985 Jul; 229(2):539-44. PubMed ID: 3929772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
